OEHHA 1996 — Evidence on Developmental and Reproductive Toxicity of Cadmium
Summary
This is the October 1996 hazard identification draft prepared by the California Office of Environmental Health Hazard Assessment Reproductive and Cancer Hazard Assessment Section for the California Developmental and Reproductive Toxicant Identification Committee. The document reviews the human epidemiological literature and the animal toxicology literature on cadmium’s developmental, female reproductive, and male reproductive effects, and served as the scientific basis for the DART ID Committee’s December 4, 1996 determination that cadmium was clearly shown to cause developmental and male reproductive toxicity. That determination produced the Proposition 65 reproductive-toxicity listing of cadmium effective May 1, 1997. The document is explicitly a hazard identification: it does not perform dose-response evaluation, exposure assessment, or derive allowable exposure levels. Those came later in the companion 2001 Maximum Allowable Daily Level document.
Key numbers
The 1996 document is qualitative by design and contains no dose-response derivation or reference value. The quantitative anchors it provides are those of the pivotal studies it reviews, which were subsequently used in the 2001 MADL derivation. The most important of these:
| Study | Endpoint | LOEL / NOEL |
|---|---|---|
| Ali et al. 1986 (rats, oral via drinking water to pregnant dams) | Developmental: decreased pup birthweight at 8.4 ppm drinking water; reduced postnatal weight gain and altered locomotor activity at 4.2 ppm | LOEL 0.706 mg/kg/day; no NOEL identified |
| Laskey et al. 1980 (rats, oral via drinking water) | Male reproductive: reduced epididymal sperm counts | LOEL 5 ppm; NOEL 1 ppm |
The document’s tables also summarize animal studies of developmental effects by inhalation (Table 1), developmental effects by oral route (Table 2), female reproductive effects by inhalation (Table 3) and oral route (Table 4), male reproductive effects by inhalation (Table 5) and oral route (Table 6), plus appendix tables for injection-route studies.
Methods (brief)
The document is a hazard identification review, not a systematic review or meta-analysis. OEHHA staff compiled and summarized published studies on cadmium’s developmental and reproductive toxicity as of late 1996, grouped by endpoint (developmental, female reproductive, male reproductive) and by route of exposure (inhalation, oral, injection). Human epidemiological data were reviewed alongside animal toxicology data, with explicit acknowledgment of the difficulty in isolating cadmium effects from confounders such as lead exposure and tobacco smoking in the human literature. The document’s function under Proposition 65 regulations is to provide the DART Identification Committee with the information needed to determine whether the chemical has been “clearly shown through scientifically valid testing according to generally accepted principles” to cause reproductive toxicity (California Health and Safety Code 25249.5 et seq., 22 CCR 12301). The Committee’s threshold is identification, not dose-response; the MADL derivation that follows the listing is a separate OEHHA regulatory act.
Limitations the document itself acknowledges. Human data on male fertility were described as very limited and inconclusive for establishing whether cadmium compromises fertility, although blood concentrations were correlated with adverse sperm parameters. Human data on birthweight and pre-term labor showed significant correlations with maternal blood or infant hair cadmium but were acknowledged as confounded. Animal developmental data were characterized as showing consistent growth deficits (reduced birthweight and reduced fetal weight) across inhalation and oral studies, with malformations reported but not consistent at environmentally relevant exposure routes.
Implications
- Certification: this document establishes the scientific basis for California’s reproductive-toxicity listing of cadmium, which is the trigger for the MADL limit of 4.1 µg/day oral that applies to consumer products sold in California. HMT&C thresholds that are tighter than the MADL reflect a precautionary posture relative to California’s implemented limit; thresholds that are looser would need explicit rationale. The listing also triggers Prop 65 warning labeling requirements for products exceeding the MADL.
- Courses: the 1996/2001 pair is a good teachable example of how US regulatory toxicology separates hazard identification from dose-response derivation and from exposure assessment. The sequence (hazard ID → listing → MADL) parallels the IRIS and JECFA workflows in their own ways.
- App: the human-data limitations noted by OEHHA (confounding by lead and smoking in birthweight and sperm-parameter studies) are relevant when consumer-facing app content references cadmium’s reproductive effects; the language should not claim an isolated cadmium effect where the underlying studies could not isolate it.
- Microbiome: not addressed in this document.
Provenance notes
License class us-government-work. Document is a state of California agency publication, functionally equivalent to a US federal government work for redistribution purposes. The OEHHA Prop 65 cadmium page (https://oehha.ca.gov/proposition-65/crnr/cadmium-causing-reproductive-toxicity) serves as the canonical landing page for verification; this document is marked “SAB DART ID Committee Draft” on every page because it was the draft released for public comment and Committee deliberation prior to the December 1996 decision. The December 1996 finalization and subsequent May 1997 listing followed this draft’s release; the draft is the operative historical record of the evidence base OEHHA presented to the Committee.
The document refers to an existing Proposition 65 cadmium listing for carcinogenicity that predates this reproductive-toxicity listing. That carcinogenicity listing (with its associated No Significant Risk Level) is a separate Prop 65 action not covered by this document or by the 2001 MADL, and is flagged on the oehha-cadmium-prop65 page as a pending ingest.